In some cases, HR-positive/HER2-negative breast cancers may over time become resistant to endocrine therapy. This can occur through mutations in the estrogen receptor ...
Crinetics Pharmaceuticals explores rare endocrine treatments, PALSONIFY development, biotechnology operations, and healthcare innovation within the Nasdaq Composite market environment.
(Beyond Pesticides, February 5, 2024) Public Comment Period Ends February 26, 2024. The U.S. Environmental Protection Agency (EPA) never completed protocol for testing pesticides that disrupt the ...
A new review was published in Volume 18 of Aging on June 11, 2026, titled "Age-related dysfunctions of the neuroendocrine ...
Many BYU students strive to take care of their health, but their efforts may be thwarted by an item as unassuming as a kitchen skillet. Utahn Cara Clark had two young children when her doctor gave her ...
Treatment Algorithms for Hormone Receptor–Positive Advanced Breast Cancer: Going Forward in Endocrine Therapy—Overcoming Resistance and Introducing New Agents ER+ breast cancers can exhibit de novo or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results